News from the FDA/CDC

Measles cases for 2019 now at postelimination high


 

Measles cases in the United States for this year have officially passed the postelimination high set in 2014, according to the Centers for Disease Control and Prevention.

Number of measles cases reported to the CDC

As of Wednesday, April 24, the case count for measles is 695, which eclipses the mark of 667 cases that had been the highest since the disease was declared to be eliminated from this country in 2000, the CDC reported.

“The high number of cases in 2019 is primarily the result of a few large outbreaks – one in Washington State and two large outbreaks in New York that started in late 2018. The outbreaks in New York City and New York State are among the largest and longest lasting since measles elimination in 2000. The longer these outbreaks continue, the greater the chance measles will again get a sustained foothold in the United States,” according to a written statement by the CDC.

Although these outbreaks began when the virus was brought into this country by unvaccinated travelers from other countries where there is widespread transmission, “a significant factor contributing to the outbreaks in New York is misinformation in the communities about the safety of the measles/mumps/rubella vaccine. Some organizations are deliberately targeting these communities with inaccurate and misleading information about vaccines,” according to the statement.

“Measles is not a harmless childhood illness, but a highly contagious, potentially life-threatening disease,” Health and Human Services Secretary Alex Azar said in a separate statement. “We have the ability to safely protect our children and our communities. Vaccines are a safe, highly effective public health solution that can prevent this disease. The measles vaccines are among the most extensively studied medical products we have, and their safety has been firmly established over many years in some of the largest vaccine studies ever undertaken. With a safe and effective vaccine that protects against measles, the suffering we are seeing is avoidable.”

Recommended Reading

Research coalition issues plan for curing hepatitis B virus
MDedge Internal Medicine
Dr. Douglas Paauw: Consider rechallenging patients with penicillin allergy
MDedge Internal Medicine
ICYMI: Anti-CD4 antibody maintains viral suppression in HIV patients post ART
MDedge Internal Medicine
Busiest week yet brings 2019 measles total to 555 cases
MDedge Internal Medicine
Diagnostic test helps clinicians identify IPF with nonsurgical biopsy
MDedge Internal Medicine
Candida auris: Dangerous and here to stay
MDedge Internal Medicine
Ibrexafungerp effective against C. auris in two early case reports
MDedge Internal Medicine
Decline in CIN2+ in younger women after HPV vaccine introduced
MDedge Internal Medicine
Gut bacterium R. gnavus linked to lupus flares
MDedge Internal Medicine
U.S. measles cases nearing postelimination-era high
MDedge Internal Medicine